Tag: Cancer screening

FDA approves imaging drug for detecting cancer after lumpectomy

Editor's Note The US Food and Drug Administration (FDA) approved Lumisight (pegulicianine), a fluorescent imaging drug used to detect cancerous tissue during lumpectomy, on April 17. Administered intravenously prior to surgery, Lumisight is designed for use with the Lumicell Direct Visualization System (DVS) or another imaging device that is FDA-approved…

Read More

By: Matt Danford
April 22, 2024
Share

Propofol anesthesia for colonoscopy could help find polyps, prevent cancer

Editor's Note By putting the patient into deeper sedation during colonoscopy, propofol could help doctors find difficult-to-spot, potentially cancerous “serrated” polyps, according to a study published April 17 in Anesthesiology. As an alternative to moderate, “conscious” sedation, propofol facilitates a more thorough exam that is more likely to identify serrated…

Read More

By: Matt Danford
April 17, 2024
Share

Report illuminates how AI transforms hospitals, healthcare

Editor's Note A paper published March 29 in the journal Bioengineering examines the growing integration of artificial intelligence (AI) into hospital and healthcare systems and the way in which it is augmenting clinical decision-making, optimizing hospital operation and management, improving medical image analysis, and transforming patient care and monitoring through…

Read More

By: Brita Belli
April 2, 2024
Share

New gel protects tissue during gastrointestinal surgery

Editor's Note Researchers at MIT have developed a new gel called GastroShield to help prevent gastrointestinal bleeding during and after surgery performed during colonoscopy screenings. Advanced Materials published the findings on February 29.  Colonoscopy screenings—undergone by some 20 million Americans each year—often result in doctors finding and removing polyps. These…

Read More

By: Brita Belli
March 15, 2024
Share

Cancer diagnoses rise; shift to younger demographic

Editor's Note:  Although overall mortality from cancer continues to decline, diagnoses continue to increase and have shifted from older to middle-aged adults. These are among the conclusions of the latest report from the American Cancer Society, which was published in CA: A Cancer Journal for Clinicians. “Among adults younger than 50…

Read More

By: Matt Danford
January 17, 2024
Share

Progress on breast cancer awareness, additional steps needed

Editor's Note Significant progress has been made in national health efforts to prompt women to look for signs of breast cancer earlier and inform them about their breast cancer risk, but continued efforts are needed, Chief Healthcare Executive October 30 reports.  Among women younger than 50, breast cancer is the…

Read More

By: Brita Belli
November 3, 2023
Share

American Cancer Society updates lung cancer screening guidelines

Editor's Note The American Cancer Society (ACS) has updated its lung cancer screening recommendations from 2013 in an effort to reduce deaths based on smoking history, CA: A Cancer Journal for Clinicians November 1 reports. According to the updated guidelines, lung cancer is the leading cause of cancer death in…

Read More

By: Brita Belli
November 1, 2023
Share

AI apps accurately diagnose pigmented skin cancer

Editor's Note A new study analyzed the accuracy of diagnosis and therapy recommendations of two AI-based smartphone apps compared to recommendations coming from doctors. The findings were published in The Lancet Digital Health in October 2023.   In the study, the AI-assisted app was compared with both medical experts and less…

Read More

By: Brita Belli
October 24, 2023
Share

Neural network AI identifies brain tumor types pre-surgery with high accuracy

Editor's Note Researchers have found a way to use artificial intelligence (AI) to identify tumor types related to brain tumors prior to surgery. The findings were published on October 11 by the journal Nature in a study titled, "Ultra-fast deep-learned CNS tumor classification during surgery." Following are some highlights, according…

Read More

By: Brita Belli
October 12, 2023
Share

Primary care reminders key to timely follow up for cancer patients with abnormal screenings

Editor's Note Patient outreach efforts, including a reminder in the electronic health record (EHR) following an abnormal cancer screening, helped to ensure timely follow-up, a new investigative study in JAMA Network reports. This cluster randomized clinical trial, titled "A multilevel primary care intervention to improve follow-up of overdue abnormal cancer…

Read More

By: Brita Belli
October 11, 2023
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat